dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Fernández Salgado, Estela |
dc.contributor.author | Robles Alonso, Virginia |
dc.contributor.author | Chaparro, María |
dc.contributor.author | Baston Rey, Iria |
dc.contributor.author | González García, Javier |
dc.contributor.author | Ramos, Laura |
dc.contributor.author | Diz-Lois Palomares, Mª Teresa |
dc.date.accessioned | 2022-12-12T13:25:18Z |
dc.date.available | 2022-12-12T13:25:18Z |
dc.date.issued | 2022-08-03 |
dc.identifier.citation | Chaparro M, Baston-Rey I, Fernández Salgado E, González García J, Ramos L, Teresa M, et al. Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab. J Clin Med. 2022 Aug 3;11(15):4518. |
dc.identifier.issn | 2077-0383 |
dc.identifier.uri | https://hdl.handle.net/11351/8651 |
dc.description | Malaltia de Crohn; Factors predictius; Ustekinumab |
dc.description.sponsorship | This work was supported by Janssen-Cilag Spain. This sponsor had a partial role in study design, analysis, and interpretation of data. |
dc.language.iso | eng |
dc.publisher | MDPI |
dc.relation.ispartofseries | Journal of Clinical Medicine;11(15) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Crohn, Malaltia de - Tractament |
dc.subject | Antiinflamatoris - Ús terapèutic |
dc.subject | Aprenentatge automàtic |
dc.subject.mesh | Machine Learning |
dc.subject.mesh | Crohn Disease |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Anti-Inflammatory Agents |
dc.title | Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3390/jcm11154518 |
dc.subject.decs | aprendizaje automático |
dc.subject.decs | enfermedad de Crohn |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | antiinflamatorios |
dc.relation.publishversion | https://doi.org/10.3390/jcm11154518 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Chaparro M] Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid, Madrid, Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain. [Baston-Rey I] Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain. [Fernández Salgado E] Complejo Hospitalario de Pontevedra, Pontevedra, Spain. [González García J] Hospital Público Comarcal la Inmaculada, Almería, Spain. [Ramos L] Hospital Universitario de Canarias, Tenerife, Spain. [Diz-Lois Palomares MT] Hospital Universitario A Coruña, A Coruña, Spain. [Robles Alonso V] Vall d’Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 35956133 |
dc.identifier.wos | 000838876800001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |